Positron Emission Tomography-Computed Tomography Imaging for Malignancies in Women

Chitra Viswanathan; Priya R. Bhosale; Shetal N. Shah; Raghunandan Vikram

doi:10.1016/j.rcl.2013.07.006

Positron Emission Tomography-Computed Tomography Imaging for Malignancies in Women

Chitra Viswanathan, Priya R. Bhosale, Shetal N. Shah, Raghunandan Vikram

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Abstract

The role of Positron Emission Tomography/Computed Tomography (PET/CT) in the evaluation of various gynecologic malignancies in light of current available data is presented and illustrated with imaging examples, pearls, and common pitfalls. 18F-fluorodeoxyglucose PET/CT is being increasingly used in management of gynecologic malignancy and has useful applications in cervical, ovarian, and endometrial carcinoma. Sensitivity and specificity are superior compared with conventional imaging. However, there are limitations of which the reporting physician should be aware. This article introduces the available evidence and discusses the role of PET/CT in various gynecologic malignancies and highlights imaging pearls and potential pitfalls.

Original language	English (US)
Pages (from-to)	1111-1125
Number of pages	15
Journal	Radiologic Clinics of North America
Volume	51
Issue number	6
DOIs	https://doi.org/10.1016/j.rcl.2013.07.006
State	Published - Nov 2013

Keywords

Cervical cancer
Endometrial cancer
Gynecologic malignancy
PET/CT
Pitfalls

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.rcl.2013.07.006

Cite this

@article{ad2baacea87f4b89b6025384d3e1558e,

title = "Positron Emission Tomography-Computed Tomography Imaging for Malignancies in Women",

abstract = "The role of Positron Emission Tomography/Computed Tomography (PET/CT) in the evaluation of various gynecologic malignancies in light of current available data is presented and illustrated with imaging examples, pearls, and common pitfalls. 18F-fluorodeoxyglucose PET/CT is being increasingly used in management of gynecologic malignancy and has useful applications in cervical, ovarian, and endometrial carcinoma. Sensitivity and specificity are superior compared with conventional imaging. However, there are limitations of which the reporting physician should be aware. This article introduces the available evidence and discusses the role of PET/CT in various gynecologic malignancies and highlights imaging pearls and potential pitfalls.",

keywords = "Cervical cancer, Endometrial cancer, Gynecologic malignancy, PET/CT, Pitfalls",

author = "Chitra Viswanathan and Bhosale, {Priya R.} and Shah, {Shetal N.} and Raghunandan Vikram",

year = "2013",

month = nov,

doi = "10.1016/j.rcl.2013.07.006",

language = "English (US)",

volume = "51",

pages = "1111--1125",

journal = "Radiologic Clinics of North America",

issn = "0033-8389",

publisher = "W.B. Saunders Ltd",

number = "6",

}

TY - JOUR

T1 - Positron Emission Tomography-Computed Tomography Imaging for Malignancies in Women

AU - Viswanathan, Chitra

AU - Bhosale, Priya R.

AU - Shah, Shetal N.

AU - Vikram, Raghunandan

PY - 2013/11

Y1 - 2013/11

N2 - The role of Positron Emission Tomography/Computed Tomography (PET/CT) in the evaluation of various gynecologic malignancies in light of current available data is presented and illustrated with imaging examples, pearls, and common pitfalls. 18F-fluorodeoxyglucose PET/CT is being increasingly used in management of gynecologic malignancy and has useful applications in cervical, ovarian, and endometrial carcinoma. Sensitivity and specificity are superior compared with conventional imaging. However, there are limitations of which the reporting physician should be aware. This article introduces the available evidence and discusses the role of PET/CT in various gynecologic malignancies and highlights imaging pearls and potential pitfalls.

AB - The role of Positron Emission Tomography/Computed Tomography (PET/CT) in the evaluation of various gynecologic malignancies in light of current available data is presented and illustrated with imaging examples, pearls, and common pitfalls. 18F-fluorodeoxyglucose PET/CT is being increasingly used in management of gynecologic malignancy and has useful applications in cervical, ovarian, and endometrial carcinoma. Sensitivity and specificity are superior compared with conventional imaging. However, there are limitations of which the reporting physician should be aware. This article introduces the available evidence and discusses the role of PET/CT in various gynecologic malignancies and highlights imaging pearls and potential pitfalls.

KW - Cervical cancer

KW - Endometrial cancer

KW - Gynecologic malignancy

KW - PET/CT

KW - Pitfalls

UR - http://www.scopus.com/inward/record.url?scp=84887176718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887176718&partnerID=8YFLogxK

U2 - 10.1016/j.rcl.2013.07.006

DO - 10.1016/j.rcl.2013.07.006

M3 - Review article

C2 - 24210447

AN - SCOPUS:84887176718

SN - 0033-8389

VL - 51

SP - 1111

EP - 1125

JO - Radiologic Clinics of North America

JF - Radiologic Clinics of North America

IS - 6

ER -

Positron Emission Tomography-Computed Tomography Imaging for Malignancies in Women

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this